David M. Mott - Director at Adaptimmune Therapeutics PLC

Issuer-level insider activity

Role
Director
Issuer ticker
ADAP
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David M. Mott since 20 Aug 2025

Reported holdings for David M. Mott in Adaptimmune Therapeutics PLC

Form 4 holding Director

Adaptimmune Therapeutics PLC

Security class
Option to purchase Ordinary Shares
Shares / value
1,583,214
Estimated value
Report date
01 Jul 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for David M. Mott in Adaptimmune Therapeutics PLC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .